NOVO NORDISK

FIASP PENFILL

Manufacturer:

NOVO NORDISK

Fiasp Penfill HCPCS:

J1812

HCPCS Code Descriptor:

Insulin (fiasp), per 5 units

Category:

J Code

Fiasp Penfill NDCs:

00169-3204-15, 00169-3205-15

Primary Type:

Insulin

Generic/Specialty Status:

Single-Source

Package Type:

Multiple

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00169-3204-15, 00169-3205-15

About Fiasp Penfill:

FIASP PENFILL is a Insulin drug manufactured by NOVO NORDISK and administered via the Subcutaneous route of administration. The J Code: J1812 is aligned to the drug FIASP PENFILL.

Fiasp Penfill is very similar to Fiasp, however this is designed for use in insulin pens. Fiasp Penfill belongs to the class of drugs known as fast acting insulins. This medication works by causing cells in the body to increase their sugar uptake, taking sugar out of the bloodstream. Fiasp Penfill is a branded medication manufactured Novo Nordisk. Patient assistance programs for this medication can be found through NovoCare.

ACCESS PRICING AND MORE BY REGISTERING

J1812 Added Date:

July 1, 2023

J1812 Effective Date:

July 1, 2023

J1812 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fiasp Penfill billing and coding information.
Fiasp Penfill patient assistance information can be found through Novo Nordisk’s NovoCare at the URL: https://www.novocare.com/diabetes/help-with-costs/pap.html
FIASP PENFILL prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for FIASP PENFILL. Please check back in a few weeks.